Welcome to the e-CCO Library!

Page: 1 2 3 ()
Ulcerative Colitis (UC) Consensus Part 1 - Definitions and diagnosis (2012)
Year: 2012
Source: JCC, Volume 6, Issue 10, 2012
Authors: Axel Dignass, Rami Eliakim, Fernando Magro, Christian Maaser, Yehuda Chowers, Karel Geboes, Gerassimos Mantzaris, Walter Reinisch, Jean-Frederic Colombel, Severine Vermeire, Simon Travis, James O. Lindsay, Gert Van Assche
Created: Wednesday, 29 August 2018, 4:52 PM by Dauren Ramankulov
Last Modified: Thursday, 30 August 2018, 10:25 AM by Dauren Ramankulov

Ulcerative colitis is a lifelong disease arising from an interaction
between genetic and environmental factors, observed predominantly
in the developed countries of the world. The precise
aetiology is unknown and therefore medical therapy to cure the
disease is not yet available. Within Europe there is a North–
South gradient, but the incidence appears to have increased in
Southern and Eastern countries in recent years. Patients may
live with a considerable symptom burden despite medical
treatment (66% describe interference with work and 73% with
leisure activities) in the hope that the aetiology of ulcerative
colitis will shortly be revealed and a cure emerge. Although this
is conceivable in the next decade, clinicians have to advise
patients on the basis of information available today. Despite
randomised trials there will always be many questions that can
only be answered by the exercise of judgement and opinion.
This leads to differences in practice between clinicians, which
may be brought into sharp relief by differences in emphasis
between countries.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Year: 2016
Source: JCC: ECCO Guidelines
Authors: Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O. Lindsay, Laurent Peyrin-Biroulet, Garret J. Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Gerassimos J. Mantzaris, Fernando Rizzello, Stephan Vavricka, Paolo Gionchetti, on behalf of ECCO
Created: Thursday, 16 March 2017, 4:30 PM by Vesna Babaja
Last Modified: Thursday, 16 March 2017, 4:34 PM by Vesna Babaja

This paper is the first in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s disease and concerns the methodology of the consensus process, and the classification, diagnosis and medical management of active and quiescent Crohn’s disease. Surgical management as well as special situations including management of perianal Crohn’s disease of this ECCO Consensus are covered in a subsequent second paper [Gionchetti et al JCC 2016].

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Year: 2016
Source: JCC: Volume 11, Issue 1, 2017
Authors: Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O. Lindsay, Laurent Peyrin-Biroulet, Garret J. Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Gerassimos J. Mantzaris, Fernando Rizzello, Stephan Vavricka, Paolo Gionchetti
Created: Friday, 31 August 2018, 10:18 AM by Dauren Ramankulov

This paper is the first in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s disease and concerns the methodology of the consensus process, and the classification, diagnosis and medical management of active and quiescent Crohn’s disease. Surgical management as well as special situations including management of perianal Crohn’s disease of this ECCO Consensus are covered in a subsequent second paper [Gionchetti et al JCC 2016].

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
Year: 2016
Source: JCC: ECCO Guidelines
Authors: Paolo Gionchetti, Axel Dignass, Silvio Danese, Fernando José Magro Dias, Gerhard Rogler, Péter Laszlo Lakatos, Michel Adamina, Sandro Ardizzone, Christianne J. Buskens, Shaji Sebastian, Silvio Laureti, Gianluca M. Sampietro, Boris Vucelic, C. Janneke van der Woude, Manuel Barreiro-de Acosta, Christian Maaser, Francisco Portela, Stephan R. Vavricka, Fernando Gomollón, on behalf of ECCO
Created: Thursday, 16 March 2017, 4:33 PM by Vesna Babaja

This paper is the second in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s disease [CD] and concerns the surgical management of CD as well as special situations including management of perianal CD and extraintestinal manifestations. Diagnostic approaches and medical management of CD of this ECCO Consensus are covered in the first paper [Gomollon et al. JCC 2016].

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
Year: 2016
Source: JCC: Volume 11, Issue 2, 2017
Authors: Paolo Gionchetti, Axel Dignass, Silvio Danese, Fernando José Magro Dias, Gerhard Rogler, Péter Laszlo Lakatos, Michel Adamina, Sandro Ardizzone, Christianne J. Buskens, Shaji Sebastian, Silvio Laureti, Gianluca M. Sampietro, Boris Vucelic, C. Janneke van der Woude, Manuel Barreiro-de Acosta, Christian Maaser, Francisco Portela, Stephan R. Vavricka, Fernando Gomollón
Created: Friday, 31 August 2018, 10:22 AM by Dauren Ramankulov

This paper is the second in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s disease [CD] and concerns the surgical management of CD as well as special situations including management of perianal CD and extraintestinal manifestations. Diagnostic approaches and medical management of CD of this ECCO Consensus are covered in the first paper [Gomollon et al. JCC 2016].

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
Year: 2014
Source: JCC, Volume 8, Issue 10, 2014
Authors: F.M. Ruemmelea, G. Veres, K.L. Kolho, A. Griffiths, A. Levineg, J.C. Escher, J. Amil Dias, A. Barabinoj, C.P. Braegger, J. Bronskyl, S. Buderus, J. Martín-de-Carpi, L. De Ridder, U.L. Fagerberg, J.P. Hugot, J. Kierkus, S. Kolacekt, S. Koletzko, P. Lionetti, E. Miele, V.M. Navas López, A. Paerregaardy, R.K. Russell, D.E. Serbanaa, R. Shaoul, P. Van Rheenenac, G. Veeremanad, B. Weiss, D. Wilsonaf, A. Dignass, A. Eliakim, H. Winter, D. Turner
Created: Thursday, 30 August 2018, 1:25 PM by Dauren Ramankulov

Children and adolescents with Crohn's disease (CD) present often with a more complicated disease course compared to adult patients. In addition, the potential impact of CD on growth, pubertal and emotional development of patients underlines the need for a specific management strategy of pediatric-onset CD. To develop the first evidenced based and consensus driven guidelines for pediatric-onset CD an expert panel of 33 IBD specialists was formed after an open call within the European Crohn's and Colitis Organisation and the European Society of Pediatric Gastroenterolog, Hepatology and Nutrition. The aim was to base on a thorough review of existing evidence a state of the art guidance on the medical treatment and long term management of children and adolescents with CD, with individualized treatment algorithms based on a benefit-risk analysis according to different clinical scenarios. In children and adolescents who did not have finished their growth, exclusive enteral nutrition (EEN) is the induction therapy of first choice due to its excellent safety profile, preferable over corticosteroids, which are equipotential to induce remission. The majority of patients with pediatric-onset CD require immunomodulator based maintenance therapy. The experts discuss several factors potentially predictive for poor disease outcome (such as severe perianal fistulizing disease, severe stricturing/penetrating disease, severe growth retardation, panenteric disease, persistent severe disease despite adequate induction therapy), which may incite to an anti-TNF-based top down approach. These guidelines are intended to give practical (whenever possible evidence-based) answers to (pediatric) gastroenterologists who take care of children and adolescents with CD; they are not meant to be a rule or legal standard, since many different clinical scenario exist requiring treatment strategies not covered by or different from these guidelines.

Crohn's Disease (CD) Consensus Part 1 - Current management (2010)
Year: 2010
Source: JCC: Volume 4, Issue 1, 2010
Authors: A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis
Created: Wednesday, 29 August 2018, 4:25 PM by Dauren Ramankulov
Last Modified: Wednesday, 29 August 2018, 4:29 PM by Dauren Ramankulov

This paper is the second in a series of three publications relating to the European evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the management of active disease, maintenance of medically induced remission and surgery. The aims and methods of the ECCO Consensus, as well as sections on diagnosis and classification are covered in the first paper [van Assche et al. JCC 2009a]. The final paper covers post-operative recurrence, fistulating disease, the management of paediatric and adolescent IBD, pregnancy, psychosomatics, extraintestinal manifestations and complementary or alternative therapy for Crohn's disease [Van Assche et al JCC 2009b]

Crohn's Disease (CD) Consensus Part 2 - Definitions & diagnosis (2010)
Year: 2010
Source: JCC: Volume 4, Issue 1, 2010
Authors: Gert Van Assche, Axel Dignass, Julian Panes, Laurent Beaugerie, John Karagiannis, Mathieu Allez, Thomas Ochsenkühn, Tim Orchard, Gerhard Rogler, Edouard Louis, Limas Kupcinskas, Gerassimos Mantzaris, Simon Travis, Eduard Stange
Created: Wednesday, 29 August 2018, 4:35 PM by Dauren Ramankulov
Crohn's Disease (CD) Consensus Part 3 - Special situations (2010)
Year: 2010
Source: JCC: Volume 4, Issue 1, 2010
Authors: Gert Van Assche, Axel Dignass, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D'Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelic, Johan Söderholm, Johanna Escher, Sibylle Koletzko, Kaija-Leena Kolho, Milan Lukas, Christian Mottet, Herbert Tilg, Séverine Vermeire, Frank Carbonnel, Andrew Cole, Gottfried Novacek, Max Reinshagen, Epameinondas Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kiesslich, Eduard Stange, Simon Travis, James Lindsay
Created: Wednesday, 29 August 2018, 4:37 PM by Dauren Ramankulov
Last Modified: Wednesday, 29 August 2018, 4:42 PM by Dauren Ramankulov
Differences in the management of pediatric and adult onset ulcerative colitis — lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis
Year: 2014
Source: JCC: Volume 8, Issue 1, 2014
Authors: Frank M. Ruemmele, Dan Turner
Created: Thursday, 30 August 2018, 11:27 AM by Dauren Ramankulov
ECCO Endoscopy Consensus (2013)
Year: 2013
Source: JCC: Volume 7, Issue 12, 2013
Authors: Vito Annesea, Marco Daperno, Matthew D. Rutter, Aurelien Amiot, Peter Bossuyt, James East, Marc Ferrante, Martin Götz, Konstantinos H. Katsanos, Ralf Kießlich, Ingrid Ordás, Alessandro Repici, Bruno Rosa, Shaji Sebastiano, Torsten Kucharzik, Rami Eliakim
Created: Thursday, 30 August 2018, 11:00 AM by Dauren Ramankulov
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
Year: 2016
Source: JCC: ECCO Position Statement
Authors: Silvio Danese, Gionata Fiorino, Tim Raine, Marc Ferrante, Karen Kemp, Jaroslaw Kierkus, Peter L. Lakatos, Gerassimos Mantzaris, Janneke van der Woude, Julian Panes, Laurent Peyrin-Biroulet
Created: Thursday, 16 March 2017, 4:39 PM by Vesna Babaja
ECCO-ESCP Consensus on Surgery for Crohn’s Disease
Year: 2017
Source: JCC: Volume 12, Issue 5, 2018
Authors: Willem A. Bemelman, Janindra Warusavitarne, Gianluca M. Sampietro, Zuzana Serclova, Oded Zmora, Gaetano Luglio, Anthony de Buck van Overstraeten, John P. Burke, Christianne J. Buskens, Francesco Colombo, Jorge Amil Dias, Rami Eliakim, Tomás Elosua, I. Ethem Gecim, Sanja Kolacek, Jaroslaw Kierkus, Kaija-Leena Kolho, Jérémie H. Lefevre, Monica Millan, Yves Panis, Thomas Pinkney, Richard K. Russell, Chaya Shwaartz, Carolynne Vaizey, Nuha Yassin, André D’Hoore
Created: Friday, 31 August 2018, 10:44 AM by Dauren Ramankulov

The aim of this Consensus is to establish up-to-date standards for timing and methodology of Surgery in Crohn’s Disease.In cooperation with ESCP, ECCO Surgeons joined forces with Paediatricians as well and parts of this Guideline will cover paediatric content.  

ECCO-ESGAR Consensus on Imaging techniques for assessment of IBD (2013)
Year: 2013
Source: JCC: Volume 7, Issue 7, 2013
Authors: J. Panes, Y. Bouhnik, W. Reinisch, J. Stoker, S.A. Taylor , D.C. Baumgart, S. Danese, S. Halligan, B. Marincek, C. Matos, L. Peyrin-Biroulet, J. Rimola, G. Rogler, G. van Assche, S. Ardizzone, A. Ba-Ssalamah, M.A. Bali, D. Bellini, L. Biancone, F. Castiglione, R. Ehehalt, R. Grassi, T. Kucharzik, F. Maccioni, G. Maconi, F. Magro , J. Martín-Comín, G. Morana, D. Pendsé, S. Sebastian, A. Signore, D. Tolan, J.A. Tielbeek, D. Weishaupt, B. Wiarda, A. Laghi
Created: Wednesday, 29 August 2018, 5:04 PM by Dauren Ramankulov
Last Modified: Thursday, 30 August 2018, 10:45 AM by Dauren Ramankulov

The ECCO-ESGAR Consensus on Imaging techniques for assessment of IBD establishes standards for the use of cross-sectional imaging techniques in IBD. Imaging will include MRI, CT and US but not endoscopy or capsule endoscopy, even though these investigations will be at the background of all discussions.

ECCO-ESP Histopathology Consensus (2013)
Year: 2013
Source: JCC: Volume 7, Issue 10, 2013
Authors: F. Magroa, C. Langner, A. Driessenc, A. Ensari d, K. Geboes, G.J. Mantzaris, V. Villanacci, G. Becheanuh, P. Borralho Nunes, G. Cathomas, W. Fries, A. Jouret-Mourinl, C. Mescoli, G. de Petris, C.A. Rubio, N.A. Shepherd, M. Vieth, R. Eliakim
Created: Thursday, 30 August 2018, 10:51 AM by Dauren Ramankulov
Last Modified: Thursday, 30 August 2018, 10:53 AM by Dauren Ramankulov

The histologic examination of endoscopic biopsies or resection specimens remains a key step in the work-up of affected inflammatory bowel disease (IBD) patients and can be used for diagnosis and differential diagnosis, particularly in the differentiation of UC from CD and other non-IBD related colitides. The introduction of new treatment strategies in inflammatory bowel disease (IBD) interfering with the patients' immune system may result in mucosal healing, making the pathologists aware of the impact of treatment upon diagnostic features. The European Crohn's and Colitis Organisation (ECCO) and the European Society of Pathology (ESP) jointly elaborated a consensus to establish standards for histopathology diagnosis in IBD. The consensus endeavors to address: (i) procedures required for a proper diagnosis, (ii) features which can be used for the analysis of endoscopic biopsies, (iii) features which can be used for the analysis of surgical samples, (iv) criteria for diagnosis and differential diagnosis, and (v) special situations including those inherent to therapy. Questions that were addressed include: how many features should be present for a firm diagnosis? What is the role of histology in patient management, including search for dysplasia? Which features if any, can be used for assessment of disease activity? The statements and general recommendations of this consensus are based on the highest level of evidence available, but significant gaps remain in certain areas.

ECCO-ESPGHAN Consensus for managing Acute Severe Ulcerative Colitis in children (2011)
Year: 2011
Source: The American Journal of Gastroenterology volume 106, pages 574–588 (2011)
Authors: Dan Turner MD, PhD, Simon P L Travis FRCP, Anne M Griffiths MD, Frank M Ruemmele MD, PhD, Arie Levine MD, Eric I Benchimol MD, PhD, Marla Dubinsky MD, George Alex MBBS, FRACP, PhD, Robert N Baldassano MD, Jacob C Langer MD, Robert Shamberger MD, Jeffrey S Hyams MD, Salvatore Cucchiara MD, PhD, Athos Bousvaros MD, MPH, Johanna C Escher MD, PhD, James Markowitz MD, David C Wilson MD, Gert van Assche MD, PhD & Richard K Russell PhD
Created: Wednesday, 29 August 2018, 4:46 PM by Dauren Ramankulov

Acute severe ulcerative colitis (ASC) is a potentially life-threatening disease. We aimed to formulate guidelines for managing ASC in children based on systematic review of the literature and robust consensus process. This manuscript is a product of a joint effort of the ECCO (European Crohn's and Colitis Organization), the Pediatric Porto Inflammatory Bowel Disease (IBD) Working group of ESPGHAN (European Society of Pediatric Gastroenterology, Hepatology, and Nutrition) and ESPGHAN.

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
Year: 2015
Source: JCC: Volume 9, Issue 3, 2015
Authors: Axel U. Dignass, Christoph Gasche, Dominik Bettenworth, Gunnar Birgegård, Silvio Danese, Javier P Gisbert, Fernando Gomollon, Tariq Iqbal, Konstantinos Katsanos, Ioannis Koutroubakis, Fernando Magro, Guillaume Savoye, Jürgen Stein, Stephan Vavricka
Created: Friday, 31 August 2018, 9:55 AM by Dauren Ramankulov

The aim of this consensus is establish up-to-date standards for the diagnosis, follow-up and management of anemia in IBD patients with a special focus on iron deficiency anemia in IBD.

European Crohn’s and Colitis Organisation Topical Review on Environmental Factors in IBD
Year: 2016
Source: JCC: Volume 11, Issue 8, 2017
Authors: Christian Maaser, Ebbe Langholz, Hannah Gordon, Johan Burisch, Pierre Ellul, Vicent Hernández Ramirez, Tarkan Karakan, Konstantinos H. Katsanos, Eduards Krustins, Arie Levine, Gerassimos J. Mantzaris, Colm O’Morain, Hans Strid, Elif Saritas Yuksel, Vito Annese
Created: Friday, 31 August 2018, 11:46 AM by Dauren Ramankulov

This ECCO Topical Review of the European Crohn’s and Colitis Organisation [ECCO] focuses on the role of environmental factors with respect to the development of inflammatory bowel disease [IBD] as well as their influence on the course of established IBD. The objective was to reach expert consensus to provide evidence-based guidance for clinical practice.

European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly
Year: 2016
Source: JCC: ECCO Topical Review
Authors: Andreas Sturm, Christian Maaser, Michael Mendall, Dimitrios Karagiannis, Pantelis Karatzas, Nienke Ipenburg, Shaji Sebastian, Fernando Rizzello, Jimmy Limdi, Konstantinos Katsanos, Carsten Schmidt, Steven Jeuring, Francesco Colombo, Paolo Gionchetti
Created: Thursday, 16 March 2017, 4:49 PM by Vesna Babaja

This ECCO topical review of the European Crohn’s and Colitis Organisation [ECCO] focuses on the epidemiology, pathophysiology, diagnosis, management and outcome of the two most common forms of inflammatory bowel disease, Crohn’s disease and ulcerative colitis, in elderly patients. The objective was to reach expert consensus to provide evidence-based guidance for clinical practice.

European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly
Year: 2016
Source: JCC: Volume 11, Issue 3, 2017
Authors: Andreas Sturm, Christian Maaser, Michael Mendall, Dimitrios Karagiannis, Pantelis Karatzas, Nienke Ipenburg, Shaji Sebastian, Fernando Rizzello, Jimmy Limdi, Konstantinos Katsanos, Carsten Schmidt, Steven Jeuring, Francesco Colombo, Paolo Gionchetti
Created: Friday, 31 August 2018, 11:35 AM by Dauren Ramankulov

This ECCO topical review of the European Crohn’s and Colitis Organisation [ECCO] focuses on the epidemiology, pathophysiology, diagnosis, management and outcome of the two most common forms of inflammatory bowel disease, Crohn’s disease and ulcerative colitis, in elderly patients. The objective was to reach expert consensus to provide evidence-based guidance for clinical practice.

Page: 1 2 3 ()